Status:
WITHDRAWN
In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
Lead Sponsor:
Applied Biology, Inc.
Collaborating Sponsors:
Hospital Universitario Ramon y Cajal
Conditions:
SARS-CoV 2
COVID
Eligibility:
MALE
18+ years
Brief Summary
The COVID-19 Androgen Sensitivity Test is a non-invasive In-Vitro Diagnostic device that utilizes Next Generation Sequencing Technology (NGS). The results of the test are used by a physician to assess...
Detailed Description
In late 2019, a novel coronavirus, subsequently named SARS-CoV-2 (COVID-19), was first reported in Hubei province in China. Since it was first reported, a worldwide pandemic has ensued affecting more ...
Eligibility Criteria
Inclusion
- Male over the age of 18
- First time present at the site
- Laboratory confirmed SARS-CoV-2 infection
- Able to give informed consent
Exclusion
- Unable to give informed consent
- Diagnosed with an additional respiratory co-infection
- XXY males
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04368897
Start Date
May 1 2020
End Date
December 1 2022
Last Update
July 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Ramon y Cajal
Madrid, Spain